• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Locoregional treatments plus immunotherapy in hepatocellular carcinoma: where do we stand?

作者信息

Rizzo Alessandro

机构信息

Struttura Semplice Dipartimentale di Oncologia Medica per la Presa in Carico Globale del Paziente Oncologico 'Don Tonino Bello,' I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II,' Viale Orazio Flacco 65, Bari, 70124, Italy.

出版信息

Future Oncol. 2022 May;18(14):1665-1668. doi: 10.2217/fon-2021-1623. Epub 2022 Feb 23.

DOI:10.2217/fon-2021-1623
PMID:35193371
Abstract
摘要

相似文献

1
Locoregional treatments plus immunotherapy in hepatocellular carcinoma: where do we stand?肝细胞癌的局部区域治疗联合免疫疗法：我们目前的进展如何？
Future Oncol. 2022 May;18(14):1665-1668. doi: 10.2217/fon-2021-1623. Epub 2022 Feb 23.
2
Emerging Trends in the Treatment of Advanced Hepatocellular Carcinoma: A Radiological Perspective.新兴的晚期肝细胞癌治疗趋势：放射学视角。
Korean J Radiol. 2021 Nov;22(11):1822-1833. doi: 10.3348/kjr.2021.0229. Epub 2021 Aug 19.
3
Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma.提高免疫疗法治疗肝细胞癌抗肿瘤效果的策略。
Front Immunol. 2021 Nov 26;12:783236. doi: 10.3389/fimmu.2021.783236. eCollection 2021.
4
Emerging Opportunities for Combining Locoregional Therapy with Immune Checkpoint Inhibitors in Hepatocellular Carcinoma.局部区域治疗与免疫检查点抑制剂联合治疗肝细胞癌的新机遇。
Curr Oncol Rep. 2020 Jun 29;22(8):76. doi: 10.1007/s11912-020-00943-6.
5
Retrospective analysis of the immunogenic effects of intra-arterial locoregional therapies in hepatocellular carcinoma: a rationale for combining selective internal radiation therapy (SIRT) and immunotherapy.回顾性分析肝细胞癌经动脉区域性局部治疗的免疫效应：选择性内放射治疗（SIRT）联合免疫治疗的原理。
BMC Cancer. 2020 Feb 19;20(1):135. doi: 10.1186/s12885-020-6613-1.
6
Combining Immune Checkpoint Inhibitors with Loco-Regional Treatments in Hepatocellular Carcinoma: Ready for Prime Time?将免疫检查点抑制剂与局部区域治疗联合应用于肝细胞癌：是否已准备好进入黄金时期？
Curr Oncol. 2024 May 31;31(6):3199-3211. doi: 10.3390/curroncol31060242.
7
Optimizing the Combination of Immunotherapy and Trans-Arterial Locoregional Therapy for Stages B and C Hepatocellular Cancer.优化免疫治疗与经动脉局部区域治疗联合用于 B 期和 C 期肝细胞癌。
Ann Surg Oncol. 2021 Mar;28(3):1499-1510. doi: 10.1245/s10434-020-09414-5. Epub 2021 Jan 3.
8
Role of locoregional therapies in the wake of systemic therapy.全身治疗后的局部区域治疗的作用。
J Hepatol. 2020 Feb;72(2):277-287. doi: 10.1016/j.jhep.2019.09.023.
9
Locoregional therapy in hepatocellular carcinoma: when to start and when to stop and when to revisit.局部区域治疗肝癌：何时开始、何时停止以及何时再次治疗。
ESMO Open. 2021 Jun;6(3):100129. doi: 10.1016/j.esmoop.2021.100129. Epub 2021 Apr 20.
10
Liver-Directed Therapies for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.肝细胞癌和肝内胆管癌的肝导向治疗
Cancer Control. 2017 Jul-Sep;24(3):1073274817729244. doi: 10.1177/1073274817729244.

引用本文的文献

1
Hepatocellular Carcinoma Immunotherapy: Predictors of Response, Issues, and Challenges.肝细胞癌免疫治疗：反应预测因素、问题与挑战。
Int J Mol Sci. 2024 Oct 15;25(20):11091. doi: 10.3390/ijms252011091.
2
Case report: The efficacy of adding high doses of intravenous vitamin C to the combination therapy of atezolizumab and bevacizumab in unresectable HCC.病例报告：在不可切除的肝癌中，将高剂量静脉注射维生素C添加到阿替利珠单抗和贝伐单抗联合治疗中的疗效。
Front Med (Lausanne). 2024 Oct 3;11:1461127. doi: 10.3389/fmed.2024.1461127. eCollection 2024.
3
Case report: Successful radical surgery following complete pathological remission of advanced HCC with Tislelizumab/Lenvatinib plus TACE.
病例报告：替雷利珠单抗/仑伐替尼联合经动脉化疗栓塞术使晚期肝癌完全病理缓解后成功进行根治性手术
Front Oncol. 2024 Aug 29;14:1369567. doi: 10.3389/fonc.2024.1369567. eCollection 2024.
4
Locoregional therapies combined with immune checkpoint inhibitors for liver metastases.局部区域疗法联合免疫检查点抑制剂治疗肝转移瘤
Cancer Cell Int. 2024 Aug 31;24(1):302. doi: 10.1186/s12935-024-03484-1.
5
Trans-Arterial Chemoembolization Plus Systemic Treatments for Hepatocellular Carcinoma: An Update.经动脉化疗栓塞联合全身治疗肝细胞癌：最新进展
J Pers Med. 2022 Oct 29;12(11):1788. doi: 10.3390/jpm12111788.
6
Challenges and Future Trends of Hepatocellular Carcinoma Immunotherapy.肝细胞癌免疫治疗的挑战与未来趋势。
Int J Mol Sci. 2022 Sep 26;23(19):11363. doi: 10.3390/ijms231911363.